Episodebeskrivelse
What role will peptides, quality and artificial intelligence play in the future of pharmaceutical compounding? In Part 2 of Medisca Off Script, Founder & CEO Antonio Dos Santos continues his conversation with CCO Charlie Guerini, exploring the importance of peptide education, the introduction of Medisca Quality (MQ) and the emerging opportunities shaping personalized medicine. From advancing quality standards and navigating regulatory challenges to the potential of AI in formulation devel...

